Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Liver Cancer Diagnostics Market size between 2026 and 2035?

The liver cancer diagnostics market size has experienced strong growth in recent years. It is projected to expand from $10.32 billion in 2025 to $11.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. The market’s historic expansion can be attributed to increasing prevalence of chronic liver diseases, rising incidence of hepatocellular carcinoma, expansion of hospital diagnostic infrastructure, growing awareness of early cancer screening, and advancements in imaging and pathology techniques.

The liver cancer diagnostics market is anticipated to experience substantial growth over the coming years. This market is projected to reach $14.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The expansion during this forecast period is primarily driven by factors such as the greater acceptance of precision oncology diagnostics, the escalating need for non-invasive diagnostic approaches, the broadening of molecular testing options, increased financial commitments to oncology research, and the expanding implementation of AI-assisted diagnostic platforms. Key trends anticipated during this time frame involve a higher uptake of sophisticated molecular diagnostic tests, a growing reliance on imaging-based tools for early detection, the increasing incorporation of biomarker-based screening techniques, the development of personalized oncology diagnostics, and a heightened emphasis on identifying cancer at early stages.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp

Which Drivers Are Impacting Market Performance In The Liver Cancer Diagnostics Market?

The liver cancer diagnostics market is anticipated to expand moving forward, driven by the increasing incidence of liver cancer. This severe condition, known as liver cancer, involves the uncontrolled multiplication and growth of liver cells. Liver cancer diagnostic tests are conducted following a primary liver carcinoma diagnosis to ascertain if cancer cells are spreading within or surrounding the liver, hence the growing occurrence of liver cancer propels the liver cancer diagnostics market. For example, in January 2023, data from the Cancer Facts & Figures 2023 report, issued by the American Cancer Society, a US-based voluntary health organization, revealed that new cases of liver and intrahepatic bile duct cancer in US females reached 13,230 in 2023. Moreover, in 2023, an estimated 41,210 new liver cancer cases were diagnosed in the US, with 29,380 individuals projected to die. Therefore, the increasing prevalence of liver cancer is fundamentally fueling the growth of the liver cancer diagnostics market.

What Segment Types Are Examined In The Liver Cancer Diagnostics Market?

The liver cancer diagnostics market covered in this report is segmented –

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma

2) By Screening: Laboratory Testing, Imaging, Biopsy, Other Screenings

3) By Technology: Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), Other Technologies

4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes

Subsegments:

1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma

What Long-Term Trends Are Expected To Shape The Future Of The Liver Cancer Diagnostics Market?

Leading companies within the liver cancer diagnostics market are creating advanced biomarker-driven assays and algorithms to improve diagnostic accuracy and aid in early detection. These diagnostic tools, referred to as biomarker-based assays and algorithms, utilize specific biological markers to identify diseases, providing more precise and efficient diagnostic capabilities. For example, in November 2023, Roche Diagnostics, a US-based biotech corporation, released the Elecsys PIVKA-II assay and Elecsys GAAD algorithm. The Elecsys PIVKA-II assay identifies elevated levels of the PIVKA-II biomarker, which is linked to hepatocellular carcinoma (HCC), thereby enhancing early detection of liver cancer in high-risk patients. Furthermore, the Elecsys GAAD algorithm integrates various diagnostic markers, such as PIVKA-II and AFP, to boost diagnostic precision and simplify decision-making in the identification of liver cancer.

Who Are The Primary Competitors In The Global Liver Cancer Diagnostics Market?

Major companies operating in the liver cancer diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Which Regions Are Poised For Strategic Growth In The Liver Cancer Diagnostics Market?

North America was the largest region in the liver cancer diagnostics market in 2025. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Liver Cancer Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10481&type=smp

Browse Through More Reports Similar to the Global Liver Cancer Diagnostics Market 2026, By The Business Research Company

Liver Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Unresectable Hepatocellular Carcinoma Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/unresectable-hepatocellular-carcinoma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company